File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Efficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis

TitleEfficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis
Authors
Huang, QLI, JSun, YWang, RCheng, XChen, H
Keywordsadjuvant treatment
epidermal growth factor receptor tyrosine kinase inhibitors
non-small cell lung cancer
operable
survival
Issue Date2016
PublisherAmerican College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.org
Citation
Chest, 2016, v. 149 n. 6, p. 1384-1392 How to Cite?
DOI: http://dx.doi.org/10.1016/j.chest.2015.12.017
AbstractBACKGROUND: The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the adjuvant treatment of non-small cell lung cancer (NSCLC) has not been well-established. Our meta-analysis aimed to determine whether the administration of EGFR-TKIs could improve the outcomes of patients with NSCLC undergoing complete resection.
Persistent Identifierhttp://hdl.handle.net/10722/235690
ISSN
0012-3692
2021 Impact Factor: 10.262
2020 SCImago Journal Rankings: 2.647
ISI Accession Number ID
WOS:000377296000019

 

DC FieldValueLanguage
dc.contributor.authorHuang, Q-
dc.contributor.authorLI, J-
dc.contributor.authorSun, Y-
dc.contributor.authorWang, R-
dc.contributor.authorCheng, X-
dc.contributor.authorChen, H-
dc.date.accessioned2016-10-14T13:54:50Z-
dc.date.available2016-10-14T13:54:50Z-
dc.date.issued2016-
dc.identifier.citationChest, 2016, v. 149 n. 6, p. 1384-1392-
dc.identifier.issn0012-3692-
dc.identifier.urihttp://hdl.handle.net/10722/235690-
dc.description.abstractBACKGROUND: The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the adjuvant treatment of non-small cell lung cancer (NSCLC) has not been well-established. Our meta-analysis aimed to determine whether the administration of EGFR-TKIs could improve the outcomes of patients with NSCLC undergoing complete resection.-
dc.languageeng-
dc.publisherAmerican College of Chest Physicians. The Journal's web site is located at http://www.chestjournal.org-
dc.relation.ispartofChest-
dc.subjectadjuvant treatment-
dc.subjectepidermal growth factor receptor tyrosine kinase inhibitors-
dc.subjectnon-small cell lung cancer-
dc.subjectoperable-
dc.subjectsurvival-
dc.titleEfficacy of EGFR tyrosine kinase inhibitors in the adjuvant treatment for operable Non-small cell lung cancer by a meta-analysis-
dc.typeArticle-
dc.identifier.doi10.1016/j.chest.2015.12.017-
dc.identifier.scopuseid_2-s2.0-84973520024-
dc.identifier.hkuros268415-
dc.identifier.volume149-
dc.identifier.issue6-
dc.identifier.spage1384-
dc.identifier.epage1392-
dc.identifier.isiWOS:000377296000019-
dc.publisher.placeUnited States-
dc.identifier.issnl0012-3692-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats